检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
作 者:黄寿国[1] 鞠亮[1] 陈波[1] 聂锋锋[1] 李明[1]
机构地区:[1]临沂市沂水中心医院骨二科,山东临沂276400
出 处:《现代生物医学进展》2015年第32期6319-6321,共3页Progress in Modern Biomedicine
摘 要:目的:研究经皮椎体成形术与保守疗法治疗胸腰椎骨质疏松性骨折的临床疗效。方法:选取2013年7月到2014年7月我院收治的胸腰椎骨质疏松性骨折患者110例,按照随机数字表法将患者分为研究组和对照组,每组55例。对照组给予保守疗法治疗,研究组给予经皮椎体成形术治疗,比较两组临床疗效,应用视觉模拟评分法(VAS)评价治疗前后的疼痛情况,并分析Cobb角度和并发症。结果:研究组总有效率90.9%显著高于对照组的76.4%(P<0.05);治疗后研究组VAS评分显著低于对照组(P<0.05);两组并发症发生率比较无统计学意义(P>0.05)。结论:经皮椎体成形术治疗胸腰椎骨质疏松性骨折具有较好的临床疗效,能有效改善腰椎部疼痛症状。Objective: To study the clinical efficacy of percutaneous vertebroplasty and conservative therapy in the treatment of thoracic and lumbar vertebrae osteoporotic fracture. Methods: A total of 110 patients with thoracic and lumbar vertebrae osteoporotic fracture, who were treated in Yishui Central Hospital of Linyi City from July 2013 to July 2014, were selected and randomly divided into study group (n=55) and control group (n=55). The control group was treated with conservative therapy, while the study group, with percutaneous vertebroplasty. The clinical efficacy of the two groups was compared; the pain status before and after treatment was evaluated by visual analogue score (VAS); the Cobb angle and the incidence of complications in the two groups were analyzed. Results: The total effective rate(90.9%) in the study group was significantly higher than that(76.4%) in the control group(P〈0.05). VAS score after treatment in the study group was significantly lower than that in the control group (P〈0.05). There was no significant difference in the incidence of complications between the two groups (P〉0.05). Conclusion: Percutaneous vertebroplasty has a good clinical efficacy in the treatment of patients with thoracic and lumbar vertebrae osteoporotic fracture,which can effectively improve the symptom of lumbar vertebrae pain.
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:216.73.216.15